再生医学市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

再生医学市场已按技术类型(干细胞疗法、生物材料、组织工程和其他类型的技术)、应用和地理细分

市场快照

Regenerative Medicine Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 19.2 %
Regenerative Medicine Market Share

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

推动全球再生医学市场增长的关键因素是越来越多地采用干细胞技术、基因疗法和组织工程,以及再生医学的技术进步。

干细胞技术是一项快速发展的技术,在再生医学中发挥着重要作用,因为它还服务于组织工程、发育细胞生物学、细胞疗法、基因治疗、化学生物学和纳米技术等学科。干细胞提供了替代细胞和组织来治疗各种疾病的可能性,包括脊髓损伤、关节炎和帕金森病等。干细胞技术在疾病治疗中的应用最终提高了这些技术在全球的整体采用率。

市场发现生物制剂、生物材料、干细胞技术和组织工程方面的重大技术进步,从而促进了市场增长。再生医学最近也取得了各种进展,包括用于移植的再生气管、3D 生物打印、用于视力丧失的干细胞治疗以及用于心脏修复的干细胞治疗。

目前的市场也见证了广泛的研发活动。除了私人参与者进行的研发活动外,学术机构也大量参与进行各种研究。因此,在全球范围内目前的研发努力下,预计未来会出现几家新的生物技术和医疗技术公司。

报告范围

根据报告的范围,再生药物用于修复、替换和再生受损伤、疾病或自然衰老过程影响的组织和器官。这些药物可恢复细胞和组织的功能,并用于多种退行性疾病,例如皮肤病、神经退行性疾病、心血管和骨科应用。

By Type of Technology
Stem Cell Therapy
Biomaterial
Tissue Engineering
Other Types of Technologies
By Application
Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

皮肤科是预计在预测期内最大的应用细分市场

据估计,皮肤科在创收中所占份额最大,而这一高贡献归因于针对皮肤科伤口和疾病的简单移植技术的存在。皮肤作为具有良好细胞复制特性的器官,从其不同层提供各种类型的干细胞。因此,存在范围广泛的产品,从治疗小损伤的贴片到用于慢性伤口和烧伤的基质和移植物。因此,预计该细分市场将在预测期内继续主导市场。

越来越多的事故和骨缺损也有望推动再生医学市场。在再生医学的帮助下,还有几项关于组织工程的研究正在进行中,以开发骨移植替代品。因此,随着骨移植的新进展,预计市场将在预测期内增长。

Regenerative Medicine Market Growth

北美占有最大份额,预计在预测期内将遵循相同趋势

由于主要参与者的存在和技术的快速进步,以及对干细胞和肿瘤学研究的大量投资,北美估计在收入方面占有最大份额。癌症和糖尿病等疾病的患病率也越来越高,现在可以通过各种干细胞疗法治愈这些疾病。此外,人们对可用干细胞程序和疗法的认识正在提高,这反过来又增加了对整个市场的需求。

Regenerative Medicine Market Report

竞争格局

全球再生医学市场竞争激烈。小公司也在与大公司合并,开发用于研究和治疗目的的组织模型。因此,公司正在对新技术进行大量投资,从而推动市场。此外,预计未来几年将很少有其他参与者进入市场。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Adoption of Stem Cell Technology

      2. 4.2.2 Technological Advancements in Regenerative Medicine

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory and Ethical Issues

      2. 4.3.2 High Cost of Treatments

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Technology

      1. 5.1.1 Stem Cell Therapy

      2. 5.1.2 Biomaterial

      3. 5.1.3 Tissue Engineering

      4. 5.1.4 Other Types of Technologies

    2. 5.2 By Application

      1. 5.2.1 Bone Graft Substitutes

      2. 5.2.2 Osteoarticular Diseases

      3. 5.2.3 Dermatology

      4. 5.2.4 Cardiovascular

      5. 5.2.5 Central Nervous System

      6. 5.2.6 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan Plc

      2. 6.1.2 Osiris Therapeutics (Smith & Nephew)

      3. 6.1.3 Integra Lifesciences

      4. 6.1.4 Cook Biotech Incorporated

      5. 6.1.5 Organogenesis Inc.

      6. 6.1.6 Baxter

      7. 6.1.7 Medtronic Plc

      8. 6.1.8 Thermo Fisher Scientific

      9. 6.1.9 Sigma-Aldrich Co.

      10. 6.1.10 Becton Dickinson and Company

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Regenerative Medicine Market market is studied from 2018 - 2026.

The Regenerative Medicine Market is growing at a CAGR of 19.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Organogenesis Inc., Allergan plc, Integra Lifesciences, Cook Biotech Incorporated, Osiris Therapeutics Inc. (Smith & Nephew) are the major companies operating in Regenerative Medicine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!